NeuClone Competitors and Similar CompaniesClear all
Assertio's competitors and similar companies include NEUWAY Pharma and Anticancer Bioscience.
 Assertio Assertio (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. |  NEUWAY Pharma NEUWAY Pharma is a company that focuses on the preclinical and clinical development of therapeutics for the treatment of severe orphan brain diseases. |  Anticancer Bioscience Anticancer Bioscience is a precision oncology company that applies synthetic lethal approaches to develop targeted cancer therapies. | |
Founding Date | Founding Date 1995 | Founding Date 2014 | Founding Date 2016 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Lake Forest, US HQ | Locations Bonn, DE HQ | Locations Chengdu Shi, CN HQ Hyderabad, IN St Andrews, GB San Francisco, US |
Employees | Employees 3058% increase | Employees 1225% decrease | Employees 15 |
Funding | |||
Total funding raised | Total funding raised $ 42.5m | Total funding raised N/A | Total funding raised $ 21m |
For sources of this data, please see the company profile
View Company Profiles
NEUWAY Pharma
HQ
Bonn, DE
Employees
12↓ 25% decrease
NEUWAY Pharma is a company that focuses on the preclinical and clinical development of therapeutics for the treatment of severe orphan brain diseases.
View companyAnticancer Bioscience
HQ
Chengdu Shi, CN
Employees
15
Anticancer Bioscience is a precision oncology company that applies synthetic lethal approaches to develop targeted cancer therapies.
View company